| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.851 | 0.001 | 0.924 | RNA-directed DNA polymerase inhibitor | 0.891 0.001 DBMET01176 0.924 0.001 DBMET01177 | DBMET01177 | |
| 0.729 | 0.005 | 0.729 | Immunomodulator | 0.652 0.008 DBMET01176 0.643 0.008 DBMET01177 | ||
| 0.61 | 0.015 | 0.66 | Immunostimulant | 0.66 0.011 DBMET01176 0.639 0.013 DBMET01177 | DBMET01176 | |
| 0.532 | 0.005 | 0.532 | Bone formation stimulant | 0.488 0.006 DBMET01176 0.464 0.007 DBMET01177 | ||
| 0.558 | 0.067 | 0.89 | DNA directed DNA polymerase inhibitor | 0.814 0.017 DBMET01176 0.89 0.009 DBMET01177 | DBMET01177 | |
| 0.481 | 0.004 | 0.793 | DNA directed RNA polymerase inhibitor | 0.729 0.003 DBMET01176 0.793 0.003 DBMET01177 | DBMET01177 | |
| 0.479 | 0.006 | 0.665 | Adenylate cyclase inhibitor | 0.641 0.003 DBMET01176 0.665 0.002 DBMET01177 | DBMET01177 | |
| 0.476 | 0.003 | 0.581 | NADH dehydrogenase inhibitor | 0.581 0.002 DBMET01176 0.58 0.002 DBMET01177 | DBMET01176 | |
| 0.479 | 0.015 | 0.597 | DNA synthesis inhibitor | 0.554 0.01 DBMET01176 0.597 0.008 DBMET01177 | DBMET01177 | |
| 0.462 | 0.001 | 0.472 | Antiviral (Hepatitis D) | 0.436 0.001 DBMET01176 0.472 0.001 DBMET01177 | DBMET01177 | |
| 0.464 | 0.004 | 0.771 | DNA polymerase I inhibitor | 0.725 0.001 DBMET01176 0.771 0.001 DBMET01177 | DBMET01177 | |
| 0.431 | 0.003 | 0.627 | Carbamoyl phosphate synthetase inhibitor | 0.591 0.001 DBMET01176 0.627 0.001 DBMET01177 | DBMET01177 | |
| 0.454 | 0.046 | 0.454 | Immunosuppressant | 0.411 0.059 DBMET01176 0.388 0.069 DBMET01177 | ||
| 0.38 | 0.062 | 0.507 | Vasodilator, peripheral | 0.428 0.047 DBMET01176 0.507 0.026 DBMET01177 | DBMET01177 | |
| 0.313 | 0.006 | 0.421 | Adenylate kinase inhibitor | 0.389 0.003 DBMET01176 0.421 0.003 DBMET01177 | DBMET01177 | |
| 0.293 | 0.026 | 0.363 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.363 0.011 DBMET01176 0.361 0.011 DBMET01177 | DBMET01176 | |
| 0.255 | 0.001 | 0.255 | Cytokine production stimulant | 0.154 0.003 DBMET01176 0.128 0.003 DBMET01177 | ||
| 0.257 | 0.004 | 0.307 | Biliverdin reductase inhibitor | 0.307 0.003 DBMET01176 0.307 0.003 DBMET01177 | DBMET01177 | |
| 0.249 | 0.002 | 0.249 | Fructose-1,6-bisphosphatase inhibitor | 0.139 0.003 DBMET01176 0.104 0.004 DBMET01177 | ||
| 0.229 | 0 | 0.286 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.252 0 DBMET01176 0.286 0 DBMET01177 | DBMET01177 | |
| 0.209 | 0.005 | 0.232 | Acyl-CoA dehydrogenase inhibitor | 0.232 0.004 DBMET01176 0.231 0.004 DBMET01177 | DBMET01176 | |
| 0.294 | 0.092 | 0.335 | Vasodilator, coronary | 0.293 0.094 DBMET01176 0.335 0.063 DBMET01177 | DBMET01177 | |
| 0.202 | 0.002 | 0.202 | Thymidine phosphorylase inhibitor | 0.102 0.003 DBMET01176 0.073 0.004 DBMET01177 | ||
| 0.196 | 0.001 | 0.196 | Purine nucleoside phosphorylase inhibitor | 0.174 0.001 DBMET01176 0.159 0.001 DBMET01177 | ||
| 0.19 | 0.01 | 0.628 | HIV-1 reverse transcriptase inhibitor | 0.556 0.004 DBMET01176 0.628 0.003 DBMET01177 | DBMET01177 | |
| 0.182 | 0.002 | 0.182 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.083 0.003 DBMET01176 0.055 0.003 DBMET01177 | ||
| 0.174 | 0.007 | 0.264 | Purinergic P2X2 antagonist | 0.229 0.004 DBMET01176 0.264 0.003 DBMET01177 | DBMET01177 | |
| 0.172 | 0.008 | 0.302 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.262 0.005 DBMET01176 0.302 0.004 DBMET01177 | DBMET01177 | |
| 0.165 | 0.004 | 0.352 | Phosphoglycerate kinase inhibitor | 0.279 0.003 DBMET01176 0.352 0.002 DBMET01177 | DBMET01177 | |
| 0.159 | 0.006 | 0.255 | Purinergic P2X1 antagonist | 0.228 0.003 DBMET01176 0.255 0.002 DBMET01177 | DBMET01177 | |
| 0.166 | 0.015 | 0.457 | Aminoacyl-tRNA synthetase inhibitor | 0.383 0.004 DBMET01176 0.457 0.003 DBMET01177 | DBMET01177 | |
| 0.217 | 0.073 | 0.217 | ErbB-1 antagonist | |||
| 0.182 | 0.041 | 0.197 | c-Src kinase inhibitor | 0.197 0.036 DBMET01176 0.186 0.04 DBMET01177 | DBMET01176 | |
| 0.137 | 0.011 | 0.294 | Ornithine carbamoyltransferase inhibitor | 0.227 0.006 DBMET01176 0.294 0.004 DBMET01177 | DBMET01177 | |
| 0.14 | 0.02 | 0.246 | Phosphofructokinase-1 inhibitor | 0.207 0.01 DBMET01176 0.246 0.008 DBMET01177 | DBMET01177 | |
| 0.121 | 0.004 | 0.148 | Inosine monophosphate dehydrogenase inhibitor | 0.148 0.004 DBMET01176 0.144 0.004 DBMET01177 | DBMET01176 | |
| 0.134 | 0.019 | 0.273 | Glutamate dehydrogenase inhibitor | 0.212 0.009 DBMET01176 0.273 0.006 DBMET01177 | DBMET01177 | |
| 0.134 | 0.029 | 0.144 | Folate antagonist | 0.144 0.024 DBMET01176 0.131 0.031 DBMET01177 | DBMET01176 | |
| 0.166 | 0.062 | 0.303 | Hexokinase inhibitor | 0.234 0.021 DBMET01176 0.303 0.01 DBMET01177 | DBMET01177 | |
| 0.106 | 0.005 | 0.112 | Adenosine deaminase inhibitor | 0.112 0.004 DBMET01176 0.109 0.004 DBMET01177 | DBMET01176 | |
| 0.17 | 0.071 | 0.17 | Src kinase inhibitor | 0.166 0.073 DBMET01176 0.153 0.081 DBMET01177 | ||
| 0.113 | 0.02 | 0.113 | Interferon agonist | 0.09 0.038 DBMET01176 0.072 0.067 DBMET01177 | ||
| 0.09 | 0.004 | 0.328 | Purinergic P2X agonist | 0.227 0.001 DBMET01176 0.328 0.001 DBMET01177 | DBMET01177 | |
| 0.092 | 0.007 | 0.187 | Thymidine kinase inhibitor | 0.148 0.004 DBMET01176 0.187 0.003 DBMET01177 | DBMET01177 | |
| 0.169 | 0.088 | 0.169 | MAP kinase kinase 5 inhibitor | |||
| 0.085 | 0.004 | 0.139 | Geranyltranstransferase inhibitor | 0.139 0.002 DBMET01176 0.138 0.002 DBMET01177 | DBMET01176 | |
| 0.089 | 0.011 | 0.331 | Purinergic P2Y antagonist | 0.261 0.004 DBMET01176 0.331 0.003 DBMET01177 | DBMET01177 | |
| 0.15 | 0.079 | 0.15 | Protein-tyrosine phosphatase inhibitor | |||
| 0.119 | 0.049 | 0.119 | Nav1.1 sodium channel blocker | |||
| 0.148 | 0.079 | 0.148 | Diuretic | |||
| 0.126 | 0.059 | 0.126 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.089 | 0.022 | 0.205 | Argininosuccinate synthase inhibitor | 0.161 0.01 DBMET01176 0.205 0.007 DBMET01177 | DBMET01177 | |
| 0.069 | 0.004 | 0.069 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.028 0.005 DBMET01176 0.024 0.005 DBMET01177 | ||
| 0.08 | 0.021 | 0.08 | Heat shock protein 90 beta antagonist | |||
| 0.067 | 0.01 | 0.068 | Squalene synthetase inhibitor | 0.068 0.01 DBMET01176 0.064 0.011 DBMET01177 | DBMET01176 | |
| 0.055 | 0.004 | 0.068 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.063 0.004 DBMET01176 0.068 0.003 DBMET01177 | DBMET01177 | |
| 0.083 | 0.037 | 0.083 | CDK2/cyclin E2 inhibitor | |||
| 0.054 | 0.012 | 0.133 | Fumarate hydratase inhibitor | 0.095 0.006 DBMET01176 0.133 0.004 DBMET01177 | DBMET01177 | |
| 0.045 | 0.005 | 0.058 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.058 0.004 DBMET01176 0.057 0.004 DBMET01177 | DBMET01176 | |
| 0.148 | 0.11 | 0.148 | Phospholipase C inhibitor | 0.146 0.115 DBMET01176 | ||
| 0.086 | 0.053 | 0.086 | ErbB-3 antagonist | |||
| 0.069 | 0.036 | 0.069 | Interferon inducer | |||
| 0.075 | 0.042 | 0.075 | Phosphodiesterase VIII inhibitor | |||
| 0.123 | 0.094 | 0.123 | Cell wall synthesis inhibitor | |||
| 0.031 | 0.003 | 0.08 | Purinergic P2Y1 agonist | 0.061 0.002 DBMET01176 0.08 0.001 DBMET01177 | DBMET01177 | |
| 0.095 | 0.067 | 0.188 | UDP-glucose 4-epimerase inhibitor | 0.148 0.03 DBMET01176 0.188 0.02 DBMET01177 | DBMET01177 | |
| 0.036 | 0.009 | 0.036 | Purinergic P2Y15 antagonist | |||
| 0.083 | 0.056 | 0.083 | T cell inhibitor | |||
| 0.026 | 0.003 | 0.029 | Methylmalonyl-CoA mutase inhibitor | 0.029 0.003 DBMET01176 0.029 0.003 DBMET01177 | DBMET01177 | |
| 0.061 | 0.038 | 0.061 | Adenosine A1 receptor antagonist | |||
| 0.026 | 0.006 | 0.077 | Purinergic P2Y1 antagonist | 0.067 0.003 DBMET01176 0.077 0.003 DBMET01177 | DBMET01177 | |
| 0.098 | 0.081 | 0.098 | GABA C receptor antagonist | |||
| 0.027 | 0.014 | 0.027 | Adenosine A1 receptor agonist | 0.025 0.015 DBMET01176 0.023 0.018 DBMET01177 | ||
| 0.035 | 0.022 | 0.198 | Purinergic P2Y2 antagonist | 0.177 0.002 DBMET01176 0.198 0.002 DBMET01177 | DBMET01177 | |
| 0.016 | 0.009 | 0.134 | Purinergic receptor agonist | 0.078 0.002 DBMET01176 0.134 0.001 DBMET01177 | DBMET01177 | |
| 0.016 | 0.009 | 0.134 | Purinergic P2 agonist | 0.078 0.002 DBMET01176 0.134 0.001 DBMET01177 | DBMET01177 | |
| 0.072 | 0.065 | 0.072 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.052 | 0.045 | 0.052 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.102 | 0.095 | 0.102 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.021 | 0.015 | 0.326 | Purinergic P2T antagonist | 0.186 0.004 DBMET01176 0.326 0.003 DBMET01177 | DBMET01177 | |
| 0.086 | 0.081 | 0.086 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.014 | 0.011 | 0.014 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.014 | 0.011 | 0.014 | Adenosine A2b receptor agonist | |||
| 0.011 | 0.01 | 0.12 | Purinergic P2Y agonist | 0.066 0.002 DBMET01176 0.12 0.001 DBMET01177 | DBMET01177 | |
| 0.04 | 0.04 | 0.107 | Antimetabolite | 0.088 0.018 DBMET01176 0.107 0.015 DBMET01177 | DBMET01177 | |
| 0.031 | 0.035 | 0.04 | Growth factor receptor-bound protein 2 antagonist | 0.04 0.014 DBMET01176 0.038 0.017 DBMET01177 | DBMET01176 | |
| 0.008 | 0.012 | 0.013 | Purinergic P2Y2 agonist | 0.011 0.006 DBMET01176 0.013 0.004 DBMET01177 | DBMET01177 | |
| 0.024 | 0.029 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 DBMET01176 0.027 0.017 DBMET01177 | DBMET01176 | |
| 0.097 | 0.112 | 0.141 | Sphingosine 1-phosphate receptor 2 agonist | 0.141 0.031 DBMET01176 0.128 0.044 DBMET01177 | DBMET01176 | |
| 0.001 | 0.019 | 0.018 | Purinergic P2Y4 agonist | 0.008 0.002 DBMET01176 0.018 0.001 DBMET01177 | DBMET01177 | |
| 0.014 | 0.032 | 0.119 | Purinergic P2Y12 antagonist | 0.069 0.005 DBMET01176 0.119 0.004 DBMET01177 | DBMET01177 | |
| 0.003 | 0.031 | 0.008 | Mannitol 2-dehydrogenase inhibitor | 0.008 0.006 DBMET01176 0.008 0.007 DBMET01177 | DBMET01177 | |
| 0.028 | 0.069 | 0.086 | Ribonucleotide reductase inhibitor | 0.07 0.031 DBMET01176 0.086 0.024 DBMET01177 | DBMET01177 | |
| 0.122 | 0.171 | 0.159 | Heat shock protein 70 antagonist | 0.144 0.062 DBMET01176 0.159 0.029 DBMET01177 | DBMET01177 | |
| 0.066 | 0.123 | 0.124 | Expectorant | 0.098 0.071 DBMET01176 0.124 0.048 DBMET01177 | DBMET01177 | |
| 0.037 | 0.114 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.043 DBMET01176 | DBMET01176 | |
| 0.019 | 0.097 | 0.06 | Purinergic P2X3 antagonist | 0.042 0.015 DBMET01176 0.06 0.008 DBMET01177 | DBMET01177 | |
| 0.025 | 0.151 | 0.052 | Farnesyltransferase inhibitor | 0.048 0.029 DBMET01176 0.052 0.026 DBMET01177 | DBMET01177 | |
| 0.006 | 0.158 | 0.031 | Sphingosine 1-phosphate receptor 3 agonist | 0.031 0.026 DBMET01176 | DBMET01176 | |
| 0.021 | 0.182 | 0.273 | Purinergic P2 antagonist | 0.196 0.007 DBMET01176 0.273 0.005 DBMET01177 | DBMET01177 | |
| 0.046 | 0.21 | 0.082 | Phosphodiesterase I inhibitor | 0.082 0.073 DBMET01177 | DBMET01177 | |
| 0.079 | 0.299 | 0.164 | Vasodilator | 0.164 0.138 DBMET01177 | DBMET01177 | |
| 0.014 | 0.727 | 0.146 | Insulin secretagoues | 0.146 0.079 DBMET01177 | DBMET01177 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |